BSE filing, NSE: FREDUN. Summary written from the filing by ALFA Finder's alert engine.
Fredun Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,469.40
- Market cap
- ₹2,106 Cr
- Revenue (annual)
- ₹635.5 Cr
- Net profit (annual)
- ₹32.62 Cr
- P/E (TTM)
- 48.0×Sector 46.5×
- Promoter holding
- 43.62%-0.95% QoQ
- FII holding
- 0.69%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fredun Pharmaceuticals Ltd
All →Fredun Pharmaceuticals Other Announcement
Fredun Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026. The disclosure provides the equity holding structure for shareholders.
Fredun Pharmaceuticals Other Announcement
Fredun Pharmaceuticals filed a compliance certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018. It confirms the processing of dematerialized shares for the quarter.
Fredun Pharmaceuticals Business Update
Fredun Pharma announces strategic pet-care acquisitions, capacity expansion, and a 100% branded portfolio target by 2029. H1 FY27 business update outlines multi-pillar growth transformation.
- manufacturing infrastructure (Palghar plant)
- 90000 sq. ft.
Fredun Pharmaceuticals Capital Structure Change
Fredun Pharmaceuticals allotted 1,82,400 equity shares upon the conversion of 60,800 warrants. The company received total consideration of ₹7.60 Crore for this warrant conversion.
- Value
- ₹7.60 Cr
Fredun Pharmaceuticals Capital Structure Change
Fredun Pharmaceuticals has allotted 1,82,400 equity shares following the conversion of 60,800 warrants into equity shares, completing the preferential issue conversion process.
Fredun Pharmaceuticals Capital Structure Change
Fredun Pharmaceuticals allotted 3,61,599 equity shares following the conversion of 1,20,533 warrants. This allotment was executed at an issue price of Rs. 1,250 per warrant.
- Value
- ₹15.07 Cr
Other convertible warrants announcements
All →Manaksia Coated Metals & Industries Convertible Warrants
Manaksia's monitoring report shows 20 lakh preferential warrants forfeited for unpaid balance, cutting the issue by Rs 9.75 crore. Objects are unfunded for the reduced amount.
- Value
- ₹9.75 Cr
Unifinz Capital India Convertible Warrants
Unifinz's EGM corrigendum seeks approval for up to 98.01 lakh warrants at ₹102 each, worth ₹99.97 Crore. Vikas Goyal's 11.33 lakh warrants are reallocated to Atika Goyal.
- Value
- ₹99.97 Cr
Avalon Technologies Convertible Warrants
Avalon Technologies issued an EGM notice for 21-Nov-2026 to approve convertible warrants via private placement and a related AoA alteration. No monetary value is disclosed in the notice.
Abhinav Leasing & Finance Convertible Warrants
Abhinav Leasing received BSE in-principle approval to issue 6 crore convertible warrants to non-promoters at ₹164 each, raising ₹984 Crore on preferential basis.
- Value
- ₹984.0 Cr
Taylormade Renewables Convertible Warrants
Taylormade Renewables called an EGM on November 18, 2026 to approve issuing up to 14,00,000 warrants to promoters at ₹71.30 each. The issue aggregates about ₹9.98 Crore.
- Value
- ₹9.98 Cr
Embassy Developments Convertible Warrants
Embassy Developments' promoter group entity converted 2.32 crore warrants into equity at INR 111.51 each. The conversion is valued at INR 258.70 crore.
- Value
- ₹258.7 Cr